ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,441Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 1171

$1.57M Total Retail Price of All Prescriptions

Rank: 11 out of 1171

836 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 836 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 836 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 13,998 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,174 489 S3 1 8
LEVOTHYROXINE SODIUM 875 604 2 4
OMEPRAZOLE 840 482 3 5
SIMVASTATIN 573 433 4 1
FUROSEMIDE 557 304 5 6
AMLODIPINE BESYLATE 509 382 6 2
LISINOPRIL 453 268 7 3
POTASSIUM CHLORIDE 397 232 8 19
GABAPENTIN 376 188 9 16
ZOLPIDEM TARTRATE 371 210 10 21
ATORVASTATIN CALCIUM 314 172 11 10
CITALOPRAM HBR 299 208 12 22
CYMBALTA 287 126 13 64
TRAMADOL HCL 285 203 14 18
NEXIUM 278 136 15 25
PRAVASTATIN SODIUM 262 177 16 13
TRAZODONE HCL 258 127 17 37
METOPROLOL TARTRATE 258 172 17 11
FLUTICASONE PROPIONATE 251 109 19 30
GLIMEPIRIDE 249 155 20 34
FLUOXETINE HCL 225 94 21 76
OXYCODONE HCL-ACETAMINOPHEN 215 79 S2 22 99
RANITIDINE HCL 214 151 23 38
HYDROCHLOROTHIAZIDE 210 167 24 9
PANTOPRAZOLE SODIUM 209 134 25 29
OXYCODONE HCL 206 33 S2 26 79
ATENOLOL 205 114 27 15
METFORMIN HCL ER 203 124 28 52
CARVEDILOL 202 168 29 20
PAROXETINE HCL 199 129 30 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 129 31 26
CYCLOBENZAPRINE HCL 191 40 R 32 67
MELOXICAM 169 109 33 56
PREDNISONE 165 103 34 39
CRESTOR 164 86 35 27
DONEPEZIL HCL 160 151 36 24
CLOPIDOGREL 156 110 37 35
AZITHROMYCIN 154 95 38 43
LOSARTAN POTASSIUM 145 141 39 14
OXYCONTIN 144 0 S2 40 186
METFORMIN HCL 136 91 41 7
METOPROLOL SUCCINATE 130 110 42 17
MIRTAZAPINE 130 84 42 50
METHADONE HCL 129 32 S2 44 144
VERAPAMIL ER 127 50 45 91
NABUMETONE 126 72 46 201
ROPINIROLE HCL 126 64 46 119
TIZANIDINE HCL 125 27 48 158
SPIRIVA 122 64 49 57
POLYETHYLENE GLYCOL 3350 114 64 50 72
LEVETIRACETAM 114 55 50 84
SERTRALINE HCL 112 69 52 23
VENLAFAXINE HCL ER 112 64 52 113
IBUPROFEN 111 33 54 80
DIOVAN HCT 111 82 54 65
MORPHINE SULFATE ER 109 11 S2 56 146
AMITRIPTYLINE HCL 109 72 R 56 74
SPIRONOLACTONE 109 49 56 53
DOXYCYCLINE HYCLATE 107 68 59 137
SINGULAIR 103 40 60 78
ESCITALOPRAM OXALATE 103 80 60 69
BUSPIRONE HCL 102 62 62 129
SYNTHROID 99 88 63 48
PROMETHAZINE HCL 98 42 R 64 87
ISOSORBIDE MONONITRATE ER 98 77 64 44
DIOVAN 98 77 64 32
PROAIR HFA 96 42 67 49
RISPERIDONE 96 42 67 77
BUPROPION HCL SR 96 23 67 224
DICYCLOMINE HCL 95 41 70 260
CARBIDOPA-LEVODOPA 94 80 71 107
ATENOLOL-CHLORTHALIDONE 93 72 72 241
LOVASTATIN 92 61 73 36
LYRICA 92 28 73 127
DICLOFENAC SODIUM 91 31 75 103
PLAVIX 91 54 75 55
PREMARIN 90 38 R 77 237
NAMENDA 89 89 78 42
CIPROFLOXACIN HCL 87 60 79 61
OPANA ER 87 20 S2 79 243
LOSARTAN-HYDROCHLOROTHIAZIDE 85 67 81 40
ALPRAZOLAM 84 56 82 184
LANSOPRAZOLE 83 42 83 150
FENTANYL 81 53 S2 84 89
ESTRADIOL 79 24 R 85 284
ALLOPURINOL 79 50 85 31
NIASPAN 77 17 87 136
PROPRANOLOL HCL 76 33 88 134
TRIAMCINOLONE ACETONIDE 75 57 89 133
WARFARIN SODIUM 73 62 90 12
ABILIFY 73 0 90 175
VOLTAREN 70 56 92 200
KLOR-CON M20 70 36 92 41
DILTIAZEM 24HR CD 70 44 92 101
DETROL LA 70 58 92 270
LANTUS SOLOSTAR 67 0 96 90
MONTELUKAST SODIUM 66 32 97 149
AMOX TR-POTASSIUM CLAVULANATE 65 39 98 142
FENOFIBRATE 64 0 99 81
DIVALPROEX SODIUM ER 64 14 99 220
LANTUS 61 19 101 46
AMOXICILLIN 61 52 101 111
VESICARE 60 37 103 203
NYSTATIN 59 40 104 128
OLANZAPINE 59 21 104 153
NAPROXEN 59 33 104 95
SUCRALFATE 58 45 107 182
BYSTOLIC 58 39 107 96
ADVAIR DISKUS 58 21 107 51
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 29 110 109
PHENYTOIN SODIUM EXTENDED 57 24 110 137
KLOR-CON M10 56 31 112 125
OXYCODONE-ACETAMINOPHEN 56 31 S2 112 59
DILTIAZEM 24HR ER 55 40 114 112
BENAZEPRIL HCL 55 30 114 83
ALENDRONATE SODIUM 55 46 114 33
DIGOXIN 53 44 117 68
HYDRALAZINE HCL 52 49 118 60
CHLORTHALIDONE 52 52 118 116
RAMIPRIL 51 45 120 85
TRIAMTERENE-HCTZ 50 11 121 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.